The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.
Condition or disease
Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 80 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Women recently diagnosed with Breast Cancer
Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania
Contraindications to MRI
previously diagnosed with breast cancer (in the smae breast) within the past 5 years
Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.